Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Announces Appointment of Peter Lawrence as President and Chief Executive Officer

April 15, 2020 07:30 AM Eastern Daylight Time BOSTON – (BUSINESS WIRE) – Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced the appointment of Peter S. Lawrence as president and chief executive officer. Mr. Lawrence joins Cardurion after […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content